Novo A/S makes big investment in lab services group
Novo A/S has finally put a part of its cash reserve to good use in the life science industry with a sizeable investment in a European provider of laboratory services – an investment that sees the venture capital group entering a new segment.
BY LOUISE WENDT JENSEN
Eivind Kolding, the CEO of Novo Nordisk parent and holding company Novo A/S, recently said that the group has about DKK 50 billion to invest, but that it has proved difficult to find worthwhile investments in the life science industry. But the venture capital company has now finally found a company to bet on.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Novo CEO: We want to focus on mature companies
For abonnenter
Kolding: It lived up to all our criteria
For abonnenter
Novo Seeds looking to expand its investment team
For abonnenter
